Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aciclovir for HSV-2 meningitis (AMEN)
2020-000033-41Phase 4Active
- Sponsor
- Aalborg University Hospital
- Start
- Jan 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in viral meningitis (VM) comparing Intravenous aciclovir, Oral valaciclovir and Placebo (3 arms). Primary endpoint: Total morbidity score >6. Started Jan 2020; status: active.
02
Drugs
aciclovirvalaciclovir
03
Conditions
viral meningitis (VM)
Beyond the preview
Go deeper on 2020-000033-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000033-41.